| Literature DB >> 1605152 |
E M Massarotti1, N Y Liu, J Mier, M B Atkins.
Abstract
Interleukin-2 (IL-2) immunotherapy resulted in the development of inflammatory arthritis in three male patients with metastatic cancer. Two patients developed a clinical picture consistent with rheumatoid arthritis. A third patient with a remote history of Reiter's syndrome developed a recrudescence of an inflammatory arthritis after treatment with IL-2. The clinical, laboratory, and histologic data on the patients and the potential pathophysiologic mechanisms are discussed.Entities:
Mesh：
Substances：
Year: 1992 PMID： 1605152 DOI： 10.1016/0002-9343(92)90789-e
Source DB: PubMed Journal: Am J Med ISSN： 0002-9343 Impact factor: 4.965